Researcher.Life Logo

Journal of Controlled Release : Impact Factor & More

eISSN: 1873-4995pISSN: 0168-3659

Aims and Scope of Journal of Controlled Release

The Journal of Controlled Release is a biweekly peer-reviewed medical journal and the official journal of the Controlled Release Society. The journal covers research on the controlled release and delivery of drugs and other biologically active agents. Announcements and reports of future meetings pertaining to the activities of the Controlled Release Society are also included. Less

Key Metrics

CiteScore
15.7
Eigenfactor
0.01 - 0.05
Impact Factor
10 - 15
Scite Index
0.93 5-Year SI
SJR
Q1Pharmaceutical Science
SNIP
1.69
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Controlled Release

Journal of Controlled Release Journal Specifications

Overview
Publisher ELSEVIER
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year1984
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Controlled Release ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Controlled Release

Engineering dynamic hydrogels to overcome translational bottlenecks in therapeutic delivery.
  • 1 Jul 2026
  • Journal of controlled release : official journal of the Controlled Release Society
Heterochiral co-assembly of β-strands and hairpins affords stereocomplexed peptide hydrogels for drug delivery.
  • 1 Jul 2026
  • Journal of controlled release : official journal of the Controlled Release Society
CXCR4-targeted lipid nanozymes for metastasis blockade and immune microenvironment reprogramming in hematological malignancies.
  • 1 Jul 2026
  • Journal of controlled release : official journal of the Controlled Release Society
Platelet cell membrane-hybridized nanobubble for universal targeted and enhanced phototherapy against bacterial infections.
  • 1 Jul 2026
  • Journal of controlled release : official journal of the Controlled Release Society
Albumin-bound alkylated resiquimod for enhanced cancer immunotherapy.
  • 1 Jul 2026
  • Journal of controlled release : official journal of the Controlled Release Society
Buforin IIb and bilirubin co-loaded CeO₂nanoparticles mitigate sepsis-related encephalopathy via synergistic anti-inflammation and neuroprotection.
  • 1 Jul 2026
  • Journal of controlled release : official journal of the Controlled Release Society
Engineering dynamic hydrogels to overcome translational bottlenecks in therapeutic delivery.
  • 1 Jul 2026
  • Journal of controlled release : official journal of the Controlled Release Society
Heterochiral co-assembly of β-strands and hairpins affords stereocomplexed peptide hydrogels for drug delivery.
  • 1 Jul 2026
  • Journal of controlled release : official journal of the Controlled Release Society
CXCR4-targeted lipid nanozymes for metastasis blockade and immune microenvironment reprogramming in hematological malignancies.
  • 1 Jul 2026
  • Journal of controlled release : official journal of the Controlled Release Society
Platelet cell membrane-hybridized nanobubble for universal targeted and enhanced phototherapy against bacterial infections.
  • 1 Jul 2026
  • Journal of controlled release : official journal of the Controlled Release Society
Albumin-bound alkylated resiquimod for enhanced cancer immunotherapy.
  • 1 Jul 2026
  • Journal of controlled release : official journal of the Controlled Release Society
Buforin IIb and bilirubin co-loaded CeO₂nanoparticles mitigate sepsis-related encephalopathy via synergistic anti-inflammation and neuroprotection.
  • 1 Jul 2026
  • Journal of controlled release : official journal of the Controlled Release Society

FAQs on Journal of Controlled Release